[Effect of thymalin and heterotransfusion on blood coagulation and fibrinolysis in thymectomized rats].
Kuznik. B I BI; Tsybikov. N N NN; Pisarevskaia. L I LI; Morozov. V G VG; Khavinson. V Kh VKh
Key Findings
- Thymectomy in rats causes hypercoagulation and reduced fibrinolysis
- Heterotransfusion induces hypocoagulation and increased fibrinolysis, but less so in thymectomized rats
- A week of thymalin restores normal coagulation and fibrinolysis in thymectomized rats and normalizes response to heterotransfusion
Practical Outcomes
- The data suggest thymalin might be useful for managing clotting disorders, but it’s only been tested in rats. No human dosing or safety info is available, so biohackers should treat this as early‑stage evidence rather than a ready‑to‑use protocol.
Summary
In rats without a thymus, blood tends to clot too much and break down clots too slowly. Giving them the peptide thymalin for a week fixed these problems and helped their blood respond normally to a blood transfusion. This shows thymalin can balance clotting and clot breakdown in this animal model.
Abstract
Experiments on rats have shown that thymectomy brings about the development of hypercoagulation and inhibition of fibrinolysis. Heterotransfusion is accompanied by hypocoagulation and stimulation of fibrinolysis in both intact and thymectomized rats. At the same time fibrinolysis in thymectomized rats is stimulated to a lesser degree than in intact animals. Preinjection into thymectomized rats of the thymus low-molecular factor thymaline over one week does not only make blood coagulation and fibrinolysis return to normal but also leads to adequate changes in the hemostatic system in response to heterotransfusion.
Study Information
pubmed
1983